News search

CNIC researchers have uncovered the evolutionary logic of the OxPhos system—the cell’s “engine”—and developed a tool to detect mutations that cause mitochondrial disease

A team from the CNIC has discovered the key role of conventional type 1 dendritic cells (cDC1) in atherosclerosis and has developed an experimental therapy with immunosuppressive nanoparticles that slows the progression of the disease in animal models.

A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto de Investigación Biomédica de Barcelona (IRB Barcelona), has identified the most effective subtype of dendritic cell for generating immune memory in response to cancer

The system provides specialised answers to biomedical questions, ensuring data privacy by operating exclusively within the CNIC

Dr. Giuseppe Danilo Norata is a Full Professor of Pharmacology at the Department of Excellence of Pharmacological and Biomolecular Sciences, University of Milan

The discovery, published in Nature, opens the path to new strategies for treating skin diseases and immunological disorders, with special potential for the treatment of inflammation, diabetes, and age-related conditions

Scientists at the CNIC have discovered how gut bacteria that cross a weakened intestinal barrier induce changes in bone marrow that strengthen the immune response

Stanford W. Ascherman Professor of Genetics, Chair of the Genetics Department and Director of the Centre for Genomics and Personalized Medicine at Stanford